Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice-Reference-Cited by-同舟云学术

Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice

Published:2020-12 Issue:12 Volume:61 Page:1565-1576
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Abulizi Abudukadier,Vatner Daniel F.^ORCID,Ye Zhang,Wang Yongliang,Camporez Joao-Paulo,Zhang Dongyan,Kahn Mario,Lyu Kun,Sirwi Alaa,Cline Gary W.^ORCID,Hussain M. Mahmood,Aspichueta Patricia,Samuel Varman T.,Shulman Gerald I.^ORCID

Funder

National Institutes of Health

Veterans Health Administration

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference45 articles.

1. Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice;Minehira;J. Lipid Res.,2008

2. Microsomal triglyceride transfer protein and its role in apolipoprotein B-lipoprotein assembly;Hussain;J. Lipid Res.,2003

3. Lipid transfer proteins in the assembly of apoB-containing lipoproteins;Sirwi;J. Lipid Res.,2018

4. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia;Wetterau;Science,1992

5. Lomitapide for the treatment of hypercholesterolemia;Berberich;Expert Opin. Pharmacother.,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon promotes increased hepatic mitochondrial oxidation and pyruvate carboxylase flux in humans with fatty liver disease;Cell Metabolism;2024-08

2. Establishment and Validation of Lactate Metabolism-Related Genes as a Prognostic Model for Gastric Cancer;Current Molecular Medicine;2024-05-09

3. Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy;Journal of Clinical Medicine;2023-10-16

4. Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy;Journal of Translational Medicine;2023-07-28

5. Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset;European Journal of Clinical Investigation;2023-06-11